Evidence map›Paper›PMID 33030630›Full record

ArticleJournal of interventional cardiac electrophysiology : an international journal of arrhythmias and pacing2021

Voltage-guided ablation in persistent atrial fibrillation-favorable 1-year outcome and predictors.

Anja Schade, Lisa Costello-Boerrigter, Frank Steinborn, Ahmet Hakan Bayri, Mykhaylo Chapran, Ralf Surber, P Christian Schulze, Violeta Mattea

Abstract read
PubMed Publisher
In one paragraph

Article in Journal of interventional cardiac electrophysiology : an international journal of arrhythmias and pacing, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed, 2 pooled it
1.8field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 2 syntheses or guidelines pooled it, 21 citations in OpenAlex.

  1. Prevalence and multiple predictors of left atrial low voltage in paroxysmal and non-paroxysmal atrial fibrillation patients undergoing ablation: a systematic review and meta-analysis.Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology · 2025
    Pooled it
  2. Pooled it
  3. Article
  4. Article
  5. Article
  6. AI-guided spatiotemporal dispersion mapping for individualized ablation in an all-comer cohort with atrial fibrillation.Journal of interventional cardiac electrophysiology : an international journal of arrhythmias and pacing · 2025
    Article
  7. Article
  8. Observational
  9. Review
  10. Review
  11. Article
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 1 country.

Anja SchadeClinic for Cardiology/ Interventional Electrophysiology, Department for Interventional Electrophysiology, Helios Hospital, Nordhäuser Str. 74, 99089, Erfurt, Germany. anja.schade@helios-gesundheit.de.ORCID http://orcid.org/0000-0003-3846-7565
Lisa Costello-BoerrigterDepartment of Cardiology and Center for Clinical Studies, Central Clinic Bad Berka, Bad Berka, Germany.
Frank SteinbornClinic for Cardiology/ Interventional Electrophysiology, Department for Interventional Electrophysiology, Helios Hospital, Nordhäuser Str. 74, 99089, Erfurt, Germany.
Ahmet Hakan BayriClinic for Cardiology/ Interventional Electrophysiology, Department for Interventional Electrophysiology, Helios Hospital, Nordhäuser Str. 74, 99089, Erfurt, Germany.
Mykhaylo ChapranClinic for Cardiology/ Interventional Electrophysiology, Department for Interventional Electrophysiology, Helios Hospital, Nordhäuser Str. 74, 99089, Erfurt, Germany.
Ralf SurberDepartment of Internal Medicine I/ Cardiology, Jena University Hospital, Jena, Germany.
P Christian SchulzeDepartment of Internal Medicine I/ Cardiology, Jena University Hospital, Jena, Germany.
Violeta MatteaClinic for Cardiology/ Interventional Electrophysiology, Department for Interventional Electrophysiology, Helios Hospital, Nordhäuser Str. 74, 99089, Erfurt, Germany.
Helios Klinikum Erfurt · DEJena University Hospital · DEZentralklinik Bad Berka · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionPulmonary vein isolation (PVI) in persistent atrial fibrillation (AF) has a low success rate. A newer ablation concept targets left atrial (LA) low voltage zones (LVZ) which correlate with fibrosis and predict recurrence after PVI. We aimed to determine the success of combined PVI- and LVZ-guided ablation and to identify the predictors for LVZ and for ablation success. METHODS AND

resultsA total of 119 consecutive patients who underwent their first ablation procedure due to persistent AF were included. After acquisition of a high-resolution LA voltage map, PVI- and LVZ-guided ablation were performed. Mean age was 69 ± 8 years, 53% were men, and 8% had longstanding persistent AF. We found LVZ in 55% of patients. Twelve-month freedom from recurrences off drugs was 69%. The only independent predictor for recurrence was the existence of LVZ (OR 4.2, 95% CI 1.54-11.41, p = 0.005). Existence of LVZ was predicted positively by age ≥ 67 years (OR 4.4, 95% CI 1.4-13.7, p = 0.011), LA volume index ≥ 68 ml/m

conclusionLVZ-guided ablation in combination with PVI results in comparably high success rates. However, the existence of LVZ remains the strongest predictor of ablation success.

Indexed as

Atrial FibrillationCatheter AblationPulmonary VeinsAgedElectrophysiologic Techniques, CardiacHumansMaleMiddle AgedRecurrenceTreatment OutcomeLow voltage guided ablationPersistent atrial fibrillationPulmonary vein isolation

Identifiers

PMID33030630
OpenAlexW3092345176

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.